Utility of cytokeratin 7 and 20 subset analysis as an aid in the identification of primary site of origin of malignancy in cytologic specimens

Diagnostic Cytopathology

Volumn 20, Issue 2, 1999, Pages 63-66

  Blumenfeld, Walter ^a   Turi, George K ^a   Harrison, George ^a   Latuszynski, Darota ^a   Zhang, Cunxian ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

CK 20; CK 7; Cytokeratins; Cytologic diagnosis; Immunocytochemistry

Indexed keywords

CYTOKERATIN; CYTOKERATIN 20; CYTOKERATIN 7; UNCLASSIFIED DRUG;

ARTICLE; CANCER CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN ANALYSIS;

BIOLOGICAL MARKERS; BIOPSY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; KERATIN-20; KERATIN-7; KERATINS; NEOPLASMS; PHENOTYPE;

EID: 0032928631     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0339(199902)20:2<63::AID-DC3>3.0.CO;2-K     Document Type: Article

References (14)

1. Miettinen M. Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. Mod Pathol 1995;8:384-388.
2. Van Niekerk CC, Jap PHK, Ramaekers CS, Van de Molengraft F, Poels LG. Immunohistochemical demonstration of keratin 7 in routinely fixed paraffin-embedded human tissues. J Pathol 1991;165:145-152.
3. Moll R, Lowe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas. Am J Pathol 1992;140:427-444.
4. Guerrieri C, Franlund B, Boeryd B. Expression of cytokeratin 7 in simultaneous mucinous tumors of the ovary and appendix. Mod Pathol 1995;8:573-576.
5. Loy TS, Calaluce RD. Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas. Am J Clin Pathol 1994;102:764-767.
6. Wauters CCAP, Smedts F, Gerrits LGM, Bosman FT, Ramaekers FCS. Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary. Hum Pathol 1995;26:852-855.
7. Loy TS, Calaluce RD, Keeney GL. Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma. Mod Pathol 1996;9:1040-1044.
8. Berezowski K, Stastny JF, Kornstein MJ. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma. Mod Pathol 1996;9:426-429.
9. Maeda T, Kajiyama K, Adachi E, Takenaka K, Sugimachi K, Tsuneyoshi M. The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver. Mod Pathol 1996;9:901-909.
10. Baars JH, De Ruijter JLM, Smedts F, et al. The applicability of a keratin 7 monoclonal antibody in routinely Papanicolaou-stained cytologic specimens for the differential diagnosis of carcinomas. Am J Clin Pathol 1994;101:257-261.
11. Sack MJ, Roberts SA. Cytokeratins 20 and 7 in the differential diagnosis of metastatic carcinoma in cytologic specimens. Diagn Cytopathol 1997;16:132-136.
12. Ascoli V, Taccogna S, Scalzo CC, Nardi F. Utility of cytokeratin 20 in identifying the origin of metastatic carcinomas in effusions. Diagn Cytopathol 1995;12:303-308.
13. Wang NP, Zee S, Zarbo RJ, Bacchi CE, Gown AM. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem 1995;3:99-107.
14. Zee S, Wang NP, Bacchi CE, Zarbo RJ, Gown AM. Cytokeratin (CK) 7 and CK 20 immunophenotyping can distinguish among carcinomas of different primary sites: an immunohistochemical study. Mod Pathol 1995;8:142A.